{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:02Z","timestamp":1754153402113,"version":"3.41.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/igc.0b013e31821743f9","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T04:01:26Z","timestamp":1306296086000},"page":"831-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Preoperative Factors Predicting Survival After Secondary Cytoreduction for Recurrent Ovarian Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Peter J.","family":"Frederick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro T.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacey","family":"McQuinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Milam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Gershenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles N.","family":"Landen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31821743f9_bb0005","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0010","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0015","unstructured":"Ozols R, Rubin S, Thomas G, et al. Epithelial ovarian cancer. In: Hoskins W, Young R, Markman Met al, eds. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:895\u2013988."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0020","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0030","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0035","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.1993.11.3.434","article-title":"Secondary cytoreduction for ovarian cancer following cisplatin therapy","volume":"11","author":"Segna","year":"1993","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0045","first-page":"1606","article-title":"Secondary cytoreductive surgery for recurrent ovarian cancer","volume":"76","author":"Eisenkop","year":"1995","journal-title":"A prospective study. Cancer."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0090-8258(89)90168-6","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"34","author":"Morris","year":"1989","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0055","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/1097-0142(19921015)70:8<2129::AID-CNCR2820700820>3.0.CO;2-U","article-title":"Radical surgical procedure improves survival time in patients with recurrent ovarian cancer","volume":"70","author":"Janicke","year":"1992","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/gyno.1995.1099","article-title":"Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response","volume":"57","author":"Vaccarello","year":"1995","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","article-title":"Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?","volume":"100","author":"Zang","year":"2004","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.2001.6143","article-title":"Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer","volume":"81","author":"Munkarah","year":"2001","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/gyno.2001.6404","article-title":"Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"83","author":"Scarabelli","year":"2001","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0085","first-page":"1008","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"99","author":"Tay","year":"2002","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1096-9098(200009)75:1<24::AID-JSO5>3.0.CO;2-L","article-title":"Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer","volume":"75","author":"Zang","year":"2000","journal-title":"J Surg Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0095","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0100","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajog.2005.06.048","article-title":"The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience","volume":"194","author":"Ayhan","year":"2006","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2007","journal-title":"Ann Surg Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2004.08.016","article-title":"Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum","volume":"31","author":"Gronlund","year":"2005","journal-title":"Eur J Surg Oncol."},{"key":"10.1097\/IGC.0b013e31821743f9_bb0125","doi-asserted-by":"crossref","unstructured":"Harter P, Sehouli J, Reuss A, et al. Predictive Factors for Resection in Recurrent Ovarian Cancer. Intergroup study of AGO Kommission Ovar, AGO-OVAR, AGO Austria, MITO and NOGGO. Bangkok, Thailand: 12th Biennial Meeting of the IGCS; 2008.","DOI":"10.1016\/S1359-6349(09)71552-6"},{"key":"10.1097\/IGC.0b013e31821743f9_bb0130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.21652","article-title":"Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients","volume":"102","author":"Sehouli","year":"2010","journal-title":"J Surg Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.lww.com\/ijgc\/Fulltext\/10.1097\/IGC.0b013e31821743f9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:12:41Z","timestamp":1753233161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24045365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1048891X24045365"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31821743f9","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Factors Predicting Survival After Secondary Cytoreduction for Recurrent Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31821743f9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}